CIP
NEO icon

Convergence Investment Partners’s NeoGenomics NEO Stock Holding History

Convergence Investment Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,647
Closed -$177K – 359
2019
Q1 		$177K Sell
8,647
-11,338
-57% -$197K 0.04% 285
2018
Q4 		$252K Buy
+19,985
New +$298K 0.06% 275

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Convergence Investment Partners's NEO Position: Q2 2019 in Review

Convergence Investment Partners sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 8,647 shares — an estimated $177K sold.

Convergence Investment Partners first reported a position in NEO in Q4 2018 and held it in 2 quarters. The position peaked at $252K in Q4 2018. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • Convergence Investment Partners reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • Convergence Investment Partners sold 8,647 NeoGenomics shares in Q2 2019, an estimated $177K.
  • Convergence Investment Partners first reported a position in NeoGenomics in Q4 2018 and held it in 2 quarters.
  • Convergence Investment Partners's NeoGenomics position peaked at $252K in Q4 2018.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on Convergence Investment Partners's 13F filing for Q2 2019, filed 23 Jul 2019.